Qingdao Baheal Medical INC. (301015) — Cash Flow Reinvestment Rate
Qingdao Baheal Medical INC. (301015) has a Cash Flow Reinvestment Rate of 0.47x as of September 2025, reinvesting CN¥107.50 Million (capex CN¥107.50 Million ) from operating cash flow of CN¥230.38 Million. See 301015 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Qingdao Baheal Medical INC. Cash Flow Reinvestment Rate (2018–2025)
Historical reinvestment intensity for Qingdao Baheal Medical INC. across 7 annual periods. For the full cash flow conversion analysis, see Qingdao Baheal Medical INC. (301015) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Qingdao Baheal Medical INC. (2018–2025)
Year-by-year capital reinvestment analysis for Qingdao Baheal Medical INC.. See 301015 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥589.21 Million | CN¥934.45 Million | CN¥288.93 Million | ▼ -30.1% |
| 2024 | 0.90x | CN¥734.15 Million | CN¥813.85 Million | CN¥303.99 Million | ▲ +109.0% |
| 2023 | 0.43x | CN¥345.01 Million | CN¥799.50 Million | CN¥185.49 Million | ▼ -40.7% |
| 2022 | 0.73x | CN¥222.65 Million | CN¥305.75 Million | CN¥105.32 Million | ▲ +162.4% |
| 2021 | 0.28x | CN¥50.31 Million | CN¥181.30 Million | CN¥27.49 Million | ▲ +92.5% |
| 2019 | 0.14x | CN¥6.63 Million | CN¥45.96 Million | CN¥2.95 Million | ▼ -49.2% |
| 2018 | 0.28x | CN¥15.74 Million | CN¥55.50 Million | CN¥15.74 Million | — |